Setiabudiawan Todia P, Apriani Lika, Verrall Ayesha J, Utami Fitria, Schneider Marion, Indrati Agnes R, Halim Pauline P, Kaplonek Paulina, Malca Hadar, Lee Jessica Shih-Lu, Moorlag Simone J C F M, de Bree L Charlotte J, Mourits Vera P, Joosten Leo A B, Netea Mihai G, Alisjahbana Bachti, McNamara Ryan P, Alter Galit, van Laarhoven Arjan, Ussher James E, Sharples Katrina, Koeken Valerie A C M, Hill Philip C, van Crevel Reinout
Department of Internal Medicine and Radboud Community for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, the Netherlands.
Research Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, Bandung, Indonesia.
Nat Commun. 2025 Jan 2;16(1):309. doi: 10.1038/s41467-024-55501-6.
Some individuals, even when heavily exposed to an infectious tuberculosis patient, do not develop a specific T-cell response as measured by interferon-gamma release assay (IGRA). This could be explained by an IFN-γ-independent adaptive immune response, or an effective innate host response clearing Mycobacterium tuberculosis (Mtb) without adaptive immunity. In heavily exposed Indonesian tuberculosis household contacts (n = 1347), a persistently IGRA negative status was associated with presence of a BCG scar, and - especially among those with a BCG scar - with altered innate immune cells dynamics, higher heterologous (Escherichia coli-induced) proinflammatory cytokine production, and higher inflammatory proteins in the IGRA mitogen tube. Neither circulating concentrations of Mtb-specific antibodies nor functional antibody activity associated with IGRA status at baseline or follow-up. In a cohort of adults in a low tuberculosis incidence setting, BCG vaccination induced heterologous innate cytokine production, but only marginally affected Mtb-specific antibody profiles. Our findings suggest that a more efficient host innate immune response, rather than a humoral response, mediates early clearance of Mtb. The protective effect of BCG vaccination against Mtb infection may be linked to innate immune priming, also termed 'trained immunity'.
一些个体,即使与传染性肺结核患者有密切接触,通过干扰素-γ释放试验(IGRA)检测也未产生特异性T细胞应答。这可以用不依赖干扰素-γ的适应性免疫应答,或在无适应性免疫的情况下有效清除结核分枝杆菌(Mtb)的先天性宿主应答来解释。在印度尼西亚大量接触结核病患者的家庭接触者(n = 1347)中,持续的IGRA阴性状态与卡介苗疤痕的存在有关,尤其是在有卡介苗疤痕的人群中,与先天性免疫细胞动态变化、更高的异源(大肠杆菌诱导)促炎细胞因子产生以及IGRA有丝分裂原管中更高的炎症蛋白有关。在基线或随访时,结核分枝杆菌特异性抗体的循环浓度或与IGRA状态相关的功能性抗体活性均无关联。在结核病发病率较低的成年人群队列中,卡介苗接种诱导了异源先天性细胞因子的产生,但仅对结核分枝杆菌特异性抗体谱有轻微影响。我们的研究结果表明,更有效的宿主先天性免疫应答而非体液应答介导了结核分枝杆菌的早期清除。卡介苗接种对结核分枝杆菌感染的保护作用可能与先天性免疫启动有关,也称为“训练免疫”。